# Comparing P1101 to Entecavir in Patients With HBeAg(-) Hepatitis B Under Long-term Nucleos(t)Ide Analogue Therapy

> **NCT05494528** · NA · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Chronic Hepatitis B Virus Infection

## Interventions

- **DRUG:** Ropeginterferon alfa-2b
- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT05494528
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-04
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2022-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05494528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05494528, "Comparing P1101 to Entecavir in Patients With HBeAg(-) Hepatitis B Under Long-term Nucleos(t)Ide Analogue Therapy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05494528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*